Literature DB >> 33663408

Sputum smear grading and associated factors among bacteriologically confirmed pulmonary drug-resistant tuberculosis patients in Ethiopia.

Getahun Molla Kassa1, Mehari Woldemariam Merid2, Atalay Goshu Muluneh1, Dawit Tefera Fentie3.   

Abstract

BACKGROUND: The sputum smear bacilliary load is a fundamental indicator of the level of infectiousness in DR-TB patients. However, evidence on DR-TB sputum smear grading and its factors in the study setting is limited. This study was aimed to determine the level of sputum smear grading and associated factors among DR-TB patients in Ethiopia.
METHODS: This was an institution based cross-sectional study on 520 bacteriological confirmed pulmonary DR-TB patients from September 2010 to December 2017 in the northwest Ethiopia. Epidata 4.2.00 and SPSS 20 were used for data entry and management, respectively. Ordinary logistic regression was fitted. A cut of p-value less than 0.05 in the multivariable ordinary logistic regression was considered to declare statistically significant variables.
RESULTS: Of all 520 bacteriological confirmed pulmonary DR-TB patients; 34.42% had 3+, 15.77% had 2+, 18.27% had 1+, 15.19% had scanty, and 16.35% had negative sputum smear grading results. The odds of having higher sputum smear grades were significantly associated with the patient's educational status of secondary (Adjusted Odds Ratio (AOR) = 0.43, 95% Confidence Interval (CI): 0.21, 0.89), body mass index of 16 to 18.49 kg/m2 (AOR = 1.81, 95%CI: 1.16, 2.84), and TB treatment history of two and more times (AOR = 1.78, 95%CI: 1.24, 2.55).
CONCLUSIONS: More than a third of the bacteriological confirmed pulmonary DR-TB patients in the study setting was highly infectious with the highest bacillary load. The odds of having a high bacillary load were significantly associated with the patient's TB treatment history, nutritional, and educational status.

Entities:  

Keywords:  Associated factors; Drug-resistant tuberculosis; Ethiopia; Sputum-smear grading

Year:  2021        PMID: 33663408      PMCID: PMC7934369          DOI: 10.1186/s12879-021-05933-y

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  19 in total

1.  Pretreatment sputum smear grade and smear positivity during follow-up of TB patients in Ahmedabad, India.

Authors:  J Patel; P Dave; S Satyanarayana; A M V Kumar; A Shah; R Ananthakrishnan; A Ratnu
Journal:  Public Health Action       Date:  2013-12-21

Review 2.  Patients at high risk of tuberculosis recurrence.

Authors:  Mehdi Mirsaeidi; Ruxana T Sadikot
Journal:  Int J Mycobacteriol       Date:  2018 Jan-Mar

3.  Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.

Authors:  M S Sander; C Y Vuchas; H N Numfor; A N Nsimen; J-L F Abena; J Noeske; A Van Deun; K L Morgan
Journal:  Int J Tuberc Lung Dis       Date:  2016-06       Impact factor: 2.373

4.  Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.

Authors:  Simmi Tiwari; Amod Kumar; S K Kapoor
Journal:  Indian J Tuberc       Date:  2012-07

5.  Infection Control for Drug-Resistant Tuberculosis: Early Diagnosis and Treatment Is the Key.

Authors:  Gilles van Cutsem; Petros Isaakidis; Jason Farley; Ed Nardell; Grigory Volchenkov; Helen Cox
Journal:  Clin Infect Dis       Date:  2016-05-15       Impact factor: 9.079

6.  Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China.

Authors:  Qiao Liu; Peng Lu; Leonardo Martinez; Haitao Yang; Wei Lu; Xiaoyan Ding; Limei Zhu
Journal:  BMC Infect Dis       Date:  2018-03-06       Impact factor: 3.090

7.  Factors Associated with Persistent Sputum Positivity at the End of the Second Month of Tuberculosis Treatment in Lithuania.

Authors:  Saulius Diktanas; Edita Vasiliauskiene; Katazyna Polubenko; Edvardas Danila; Indre Celedinaite; Evelina Boreikaite; Kipras Misiunas
Journal:  Tuberc Respir Dis (Seoul)       Date:  2018-06-19

8.  Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali.

Authors:  Bocar Baya; Chad J Achenbach; Bourahima Kone; Yacouba Toloba; Djeneba K Dabitao; Bassirou Diarra; Drissa Goita; Seydou Diabaté; Mamoudou Maiga; Dianguina Soumare; Khadidia Ouattara; Tenin Kanoute; Gaoussou Berthe; Youssouf M Kamia; Yeya Dit Sadio Sarro; Moumine Sanogo; Antieme C G Togo; Bindongo P P Dembele; Nadie Coulibaly; Amadou Kone; Maxwell Akanbi; Michael Belson; Sounkalo Dao; Susan Orsega; Sophia Siddiqui; Seydou Doumbia; Robert L Murphy; Souleymane Diallo
Journal:  Int J Infect Dis       Date:  2019-02-14       Impact factor: 3.623

9.  Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: A retrospective study.

Authors:  Ye Minn Htun; Tin Mi Mi Khaing; Nay Myo Aung; Yin Yin; Zaw Myint; Si Thu Aung; Ngamphol Soonthornworasiri; Udomsak Silachamroon; Yuthichai Kasetjaroen; Jaranit Kaewkungwal
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

10.  Risk factors for poor treatment outcomes of 2266 multidrug-resistant tuberculosis cases in Ho Chi Minh City: a retrospective study.

Authors:  Le Hong Van; Phan Trieu Phu; Dao Nguyen Vinh; Vo Thanh Son; Nguyen Thi Hanh; Le Thanh Hoang Nhat; Nguyen Huu Lan; Truong Van Vinh; Nguyen Thi Mai Trang; Dang Thi Minh Ha; Guy E Thwaites; Nguyen Thuy Thuong Thuong
Journal:  BMC Infect Dis       Date:  2020-02-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.